9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia

Bhavana J Dave, Michele Wiggins, Christine M. Higgins, Diane L. Pickering, Deborah Perry, Patricia Aoun, Minnie Abromowich, Marcel P DeVetten, Warren G. Sanger

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The t(9;22)(q11.2;q34) translocation is found in a subset of acute lymphoblastic leukemia (ALL). The presence of this translocation involving the fusion of BCR/ABL genes represents a poor prognostic group. Because of the importance in detecting t(9;22) in ALL patients and because occasionally a cytogenetically cryptic BCR/ABL fusion is detected with fluorescence in situ hybridization (FISH), our laboratory routinely performs BCR/ABL FISH tests on all newly diagnosed ALL patients. In the past year, 25 consecutive, newly diagnosed, untreated ALL cases were analyzed. We report the cytogenetics and FISH findings of three cases containing a rearranged 9q34 region with an intact BCR (22q11.2) region and an absence of the BCR/ABL fusion. A split ABL signal representing a translocation of the 9q34 region with chromosome segments other than 22q11.2 (BCR) was observed in 3 cases. Two of these patients were 3 years old; one was 21 at the time of diagnosis. A split ABL FISH signal without the involvement of BCR does not represent a t(9;22) translocation, and prognostic implications of this apparent subgroup of ALL cases have not been determined. Cytogenetic, pathologic, and clinical aspects of these three cases are presented.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalCancer genetics and cytogenetics
Volume162
Issue number1
DOIs
StatePublished - Oct 1 2005

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Fluorescence In Situ Hybridization
Cytogenetics
Chromosomes
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Dave, B. J., Wiggins, M., Higgins, C. M., Pickering, D. L., Perry, D., Aoun, P., ... Sanger, W. G. (2005). 9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia. Cancer genetics and cytogenetics, 162(1), 30-37. https://doi.org/10.1016/j.cancergencyto.2005.03.005

9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia. / Dave, Bhavana J; Wiggins, Michele; Higgins, Christine M.; Pickering, Diane L.; Perry, Deborah; Aoun, Patricia; Abromowich, Minnie; DeVetten, Marcel P; Sanger, Warren G.

In: Cancer genetics and cytogenetics, Vol. 162, No. 1, 01.10.2005, p. 30-37.

Research output: Contribution to journalArticle

Dave, BJ, Wiggins, M, Higgins, CM, Pickering, DL, Perry, D, Aoun, P, Abromowich, M, DeVetten, MP & Sanger, WG 2005, '9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia', Cancer genetics and cytogenetics, vol. 162, no. 1, pp. 30-37. https://doi.org/10.1016/j.cancergencyto.2005.03.005
Dave, Bhavana J ; Wiggins, Michele ; Higgins, Christine M. ; Pickering, Diane L. ; Perry, Deborah ; Aoun, Patricia ; Abromowich, Minnie ; DeVetten, Marcel P ; Sanger, Warren G. / 9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia. In: Cancer genetics and cytogenetics. 2005 ; Vol. 162, No. 1. pp. 30-37.
@article{5f8c8811361f436e857e4ce0ae405522,
title = "9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia",
abstract = "The t(9;22)(q11.2;q34) translocation is found in a subset of acute lymphoblastic leukemia (ALL). The presence of this translocation involving the fusion of BCR/ABL genes represents a poor prognostic group. Because of the importance in detecting t(9;22) in ALL patients and because occasionally a cytogenetically cryptic BCR/ABL fusion is detected with fluorescence in situ hybridization (FISH), our laboratory routinely performs BCR/ABL FISH tests on all newly diagnosed ALL patients. In the past year, 25 consecutive, newly diagnosed, untreated ALL cases were analyzed. We report the cytogenetics and FISH findings of three cases containing a rearranged 9q34 region with an intact BCR (22q11.2) region and an absence of the BCR/ABL fusion. A split ABL signal representing a translocation of the 9q34 region with chromosome segments other than 22q11.2 (BCR) was observed in 3 cases. Two of these patients were 3 years old; one was 21 at the time of diagnosis. A split ABL FISH signal without the involvement of BCR does not represent a t(9;22) translocation, and prognostic implications of this apparent subgroup of ALL cases have not been determined. Cytogenetic, pathologic, and clinical aspects of these three cases are presented.",
author = "Dave, {Bhavana J} and Michele Wiggins and Higgins, {Christine M.} and Pickering, {Diane L.} and Deborah Perry and Patricia Aoun and Minnie Abromowich and DeVetten, {Marcel P} and Sanger, {Warren G.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.cancergencyto.2005.03.005",
language = "English (US)",
volume = "162",
pages = "30--37",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - 9q34 Rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia

AU - Dave, Bhavana J

AU - Wiggins, Michele

AU - Higgins, Christine M.

AU - Pickering, Diane L.

AU - Perry, Deborah

AU - Aoun, Patricia

AU - Abromowich, Minnie

AU - DeVetten, Marcel P

AU - Sanger, Warren G.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - The t(9;22)(q11.2;q34) translocation is found in a subset of acute lymphoblastic leukemia (ALL). The presence of this translocation involving the fusion of BCR/ABL genes represents a poor prognostic group. Because of the importance in detecting t(9;22) in ALL patients and because occasionally a cytogenetically cryptic BCR/ABL fusion is detected with fluorescence in situ hybridization (FISH), our laboratory routinely performs BCR/ABL FISH tests on all newly diagnosed ALL patients. In the past year, 25 consecutive, newly diagnosed, untreated ALL cases were analyzed. We report the cytogenetics and FISH findings of three cases containing a rearranged 9q34 region with an intact BCR (22q11.2) region and an absence of the BCR/ABL fusion. A split ABL signal representing a translocation of the 9q34 region with chromosome segments other than 22q11.2 (BCR) was observed in 3 cases. Two of these patients were 3 years old; one was 21 at the time of diagnosis. A split ABL FISH signal without the involvement of BCR does not represent a t(9;22) translocation, and prognostic implications of this apparent subgroup of ALL cases have not been determined. Cytogenetic, pathologic, and clinical aspects of these three cases are presented.

AB - The t(9;22)(q11.2;q34) translocation is found in a subset of acute lymphoblastic leukemia (ALL). The presence of this translocation involving the fusion of BCR/ABL genes represents a poor prognostic group. Because of the importance in detecting t(9;22) in ALL patients and because occasionally a cytogenetically cryptic BCR/ABL fusion is detected with fluorescence in situ hybridization (FISH), our laboratory routinely performs BCR/ABL FISH tests on all newly diagnosed ALL patients. In the past year, 25 consecutive, newly diagnosed, untreated ALL cases were analyzed. We report the cytogenetics and FISH findings of three cases containing a rearranged 9q34 region with an intact BCR (22q11.2) region and an absence of the BCR/ABL fusion. A split ABL signal representing a translocation of the 9q34 region with chromosome segments other than 22q11.2 (BCR) was observed in 3 cases. Two of these patients were 3 years old; one was 21 at the time of diagnosis. A split ABL FISH signal without the involvement of BCR does not represent a t(9;22) translocation, and prognostic implications of this apparent subgroup of ALL cases have not been determined. Cytogenetic, pathologic, and clinical aspects of these three cases are presented.

UR - http://www.scopus.com/inward/record.url?scp=24644471889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644471889&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2005.03.005

DO - 10.1016/j.cancergencyto.2005.03.005

M3 - Article

C2 - 16157197

AN - SCOPUS:24644471889

VL - 162

SP - 30

EP - 37

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -